Coupled Inspiratory and Expiratory Muscle Training in Children With Bronchial Asthma
The Rationale of Applying Inspiratory/Expiratory Muscle Training Within the Same Respiratory Cycle in Children With Bronchial Asthma: A Placebo-controlled Randomized Clinical Trial
1 other identifier
interventional
51
1 country
1
Brief Summary
This study was designed to assess the effect of inspiratory and expiratory muscle training in the same cycle on respiratory muscle strength, pulmonary functions, perception of asthma symptoms in children with bronchial asthma. Fifty-one children with bronchial asthma were randomly allocated to the unloaded respiratory muscle training (Placebo training group; n = 17), inspiratory muscle training alone (inspiratory muscle training group; n = 17), or combined inspiratory and expiratory muscle training in the same cycle (combined training group; n = 17). All groups were assessed for respiratory muscle strength, pulmonary functions, and asthma symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2021
CompletedFirst Submitted
Initial submission to the registry
January 3, 2022
CompletedFirst Posted
Study publicly available on registry
January 28, 2022
CompletedJanuary 28, 2022
January 1, 2022
1.2 years
January 3, 2022
January 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Inspiratory muscle strength
Inspiratory muscle strength was assessed by measuring the maximal inspiratory pressure (reflects the strength of the diaphragm and other inspiratory muscles) using an electronic respiratory pressure meter, according to the American Thoracic Society and European Respiratory Society standards. The highest value of three acceptable trials was documented and used for the subsequent analysis. The percent predicted maximal inspiratory pressure values (%) were calculated and used for statistical analysis.
2 months
Expiratory muscle strength
Expiratory muscle strength was assessed by measuring the maximal expiratory pressure (reflects the strength of the abdominal muscles and other expiratory muscles) using an electronic respiratory pressure meter, according to the American Thoracic Society and European Respiratory Society standards. The highest value of three acceptable trials was documented and used for the subsequent analysis. The percent predicted maximal inspiratory pressure values (%) were calculated and used for statistical analysis.
2 months
Forced vital capacity
Forced vital capacity, which is the amount of air that each participant was able to forcibly exhale from his/her lungs after taking the deepest breath they can, was measured in a pulmonary function test with a spirometry analyzer and expressed as a percentage of predicted values (%). Three trials were allowed and the best results were recorded.
2 months
Forced expiratory volume in one second
Forced expiratory volume in one second, which is the volume of air exhaled in the first second during forced exhalation after a maximal inspiration, was measured in a pulmonary function test with a spirometry analyzer and expressed as a percentage of predicted values (%). Three trials were allowed and the best results were recorded.
2 months
Forced expiratory volume in one second / forced vital capacity
Forced expiratory volume in one second / forced vital capacity, is the ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs.
2 months
Secondary Outcomes (1)
Asthma symptoms
2 months
Study Arms (3)
Placebo group
PLACEBO COMPARATORThis group received a conventional respiratory retraining program plus unloaded (placebo) respiratory muscle training
Inspiratory muscle training group
ACTIVE COMPARATORThis group received a conventional respiratory retraining program plus inspiratory muscle training only
Combined training group
EXPERIMENTALThis group received a conventional respiratory retraining program plus inspiratory and expiratory muscle training in the same respiratory cycle.
Interventions
Unloaded respiratory muscle training plus conventional respiratory exercises
Inspiratory muscle training plus conventional respiratory exercises
Combined inspiratory and expiratory muscle training in the same respiratory cycle plus conventional respiratory exercises.
Eligibility Criteria
You may qualify if:
- Confirmed diagnosis of asthma according to Global Initiative of Asthma guidelines.
- Age between 12 and 18 years.
- Clinically stable asthma.
- Stable doses of medications in the last three months
- A percent-predicted value of the peak expiratory flow rate of 60-80%
- No activity limitation due to asthma
You may not qualify if:
- Unstable asthma
- Exacerbation of asthma symptoms
- History of thoracic surgery
- Cognitive/behavioral problems
- Cardiopulmonary co-morbidities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Ragab K. Elnaggar
Al Kharj, Riyadh Region, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ragab K Elnaggar, PhD
Prince Sattam Bin Abdulaziz University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor was blinded to the treatment allocation
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 3, 2022
First Posted
January 28, 2022
Study Start
August 2, 2020
Primary Completion
October 28, 2021
Study Completion
October 28, 2021
Last Updated
January 28, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share